Back to Search
ANDRES FORERO-TORRES, MD
MD
Hematology & Oncology Physician
NPI: 1265476352Individual
Specialties, Licenses & Credentials
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
25015(AL)
Research & Publications (8)
A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma.
PMID 19466965·Br J Haematol·2009
3-trial
Bendamustine in non-Hodgkin lymphoma: the double-agent that came from the Cold War.
PMID 18282361·Clin Lymphoma Myeloma·2007
6-review
Pretargeted radioimmunotherapy (RIT) with a novel anti-TAG-72 fusion protein.
PMID 16114986·Cancer Biother Radiopharm·2005
3-trial
Phase I study of the humanized anti-CD40 monoclonal antibody dacetuzumab in refractory or recurrent non-Hodgkin's lymphoma.
PMID 19636010·J Clin Oncol·2009
3-trial
Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study.
PMID 18182663·J Clin Oncol·2008
3-trial
A phase I/II study of galiximab (an anti-CD80 monoclonal antibody) in combination with rituximab for relapsed or refractory, follicular lymphoma.
PMID 17470451·Ann Oncol·2007
3-trial
Diffuse F-18 FDG uptake in skeletal muscles secondary to chills resulting from sepsis: a cause for underestimation of viable tumor.
PMID 15311141·Clin Nucl Med·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Request Appointment
This provider isn't set up for online booking yet. Once you submit, we'll reach out to their office to arrange secure delivery of your request.
Contact & Hours
- Address
- 619 19TH ST S
BIRMINGHAM, AL 35249 - Phone
- (205) 934-6600
Quick Facts
- NPI
- 1265476352
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 8
Are you this provider?
Claim Your Profile